NC underfunds mental health. It hits trans kids the hardest.
When North Carolina lawmakers allocated $835 million to shore up mental health infrastructure in 2023, none of the money was allocated to meet the specific needs of trans patients.
When North Carolina lawmakers allocated $835 million to shore up mental health infrastructure in 2023, none of the money was allocated to meet the specific needs of trans patients.
Eli Lilly, Sanofi, and Novo Nordisk’s price cuts are expected to benefit many North Carolinians who need insulin to survive. The companies first announced the moves last year, as a response to an American Rescue Plan provision that threatened to penalize them if they kept prices high.
North Carolina used American Rescue Plan dollars to fund wage increases for at-home caregivers and launch a fund to recruit and retain workers.
Almost 50 water systems in NC have been found to have high levels of toxic PFAS. Here’s how to test if your water has them, or other toxins, in it.
Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.
After a decade of delay, Medicaid expansion is official in North Carolina. Here’s a guide on who can apply and how to do it most easily.
President Biden’s 2021 American Rescue Plan provided a $1.7 billion “signing bonus” to North Carolina to expand Medicaid, which Gov. Roy Cooper described as "a major part of our successful effort to finally get Medicaid expansion."
In North Carolina, $8.4 billion in funding has been announced, with over 300 specific infrastructure projects identified for funding. Nearly $6 billion will go to transit upgrades, and another $469 million for clean water and water infrastructure.
The provision, signed into law by President Biden, will significantly lower out-of-pocket drug costs for many of the nearly 1.7 million North Carolina seniors enrolled in Medicare Part D coverage, starting in 2026.
Starting in 2026, the prices for these drugs will decrease for up to nine million seniors, thanks to a provision in President Biden’s Inflation Reduction Act that allows Medicare to negotiate the prices for these drugs directly with the manufacturers.